African trypanosome control in the insect vector and mammalian host

Trends in Parasitology

Volumn 30, Issue 11, 2014, Pages 538-547

  Beschin, Alain ^a,b   Van Den Abbeele, Jan ^c,d   De Baetselier, Patrick ^a,b   Pays, Etienne ^e,f  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f Walloon Excellence in Life Sciences and Biotechnology (WELBIO   (Belgium)

Author keywords

Inflammation; Liver; Macrophages; Monocytes; Myeloid cells; Tsetse fly

Indexed keywords

ADENYLATE CYCLASE; DNA A; PEPTIDOGLYCAN RECOGNITION PROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; VARIANT SURFACE GLYCOPROTEIN; INSECT PROTEIN;

ADULT; AFRICAN; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; DEFENSE MECHANISM; DISEASE CARRIER; GLOSSINA; GLOSSINIDAE; HEAVY CHAIN; HOST; HOST RESISTANCE; IMMUNE DEFICIENCY; INFECTION CONTROL; INFECTION RESISTANCE; MAMMAL; MOUSE; NONHUMAN; PARASITE LOAD; PARASITE TRANSMISSION; PARASITOSIS; PATHOGENICITY; REGULATORY MECHANISM; REVIEW; SALIVA; TRYPANOSOMA; TRYPANOSOMIASIS; AFRICAN TRYPANOSOMIASIS; ANIMAL; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; PARASITOLOGY; PHYSIOLOGY; TRANSMISSION; TRYPANOSOMA BRUCEI BRUCEI;

ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; INSECT PROTEINS; INSECT VECTORS; MAMMALS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; TSETSE FLIES;

EID: 84908214264     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2014.08.006     Document Type: Review

References (107)

1. La Greca F., Magez S. Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?. Hum. Vaccin. 2011, 7:1225-1233.
2. WHO Control and surveillance of human African trypanosomiasis. World Health Organ. Tech. Rep. Ser. 2013, 984:1-237.
3. Desquesnes M., et al. Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects. Biomed. Res. Int. 2013, 2013:194176.
4. Sears B.F., et al. The economy of inflammation: when is less more?. Trends Parasitol. 2011, 27:382-387.
5. Medzhitov R., et al. Disease tolerance as a defense strategy. Science 2012, 335:936-941.
6. Losos G.J., Ikede B.O. Review of pathology of diseases in domestic and laboratory animals caused by Trypanosoma congolense, T. vivax, T. brucei, T. rhodesiense and T. gambiense. Vet. Pathol. 1972, 9(Suppl.):1-79.
7. Peacock L., et al. The influence of sex and fly species on the development of trypanosomes in tsetse flies. PLoS Negl. Trop. Dis. 2012, 6:e1515.
8. Auty H.K., et al. Using molecular data for epidemiological inference: assessing the prevalence of Trypanosoma brucei rhodesiense in tsetse in Serengeti, Tanzania. PLoS Negl. Trop. Dis. 2012, 6:e1501.
9. Haines L.R. Examining the tsetse teneral phenomenon and permissiveness to trypanosome infection. Front. Cell. Infect. Microbiol. 2013, 3:84.
10. Rotureau B., Van Den Abbeele J. Through the dark continent: African trypanosome development in the tsetse fly. Front. Cell. Infect. Microbiol. 2013, 3:53.
11. Van Den Abbeele J., et al. Trypanosoma brucei spp. development in the tsetse fly: characterization of the post-mesocyclic stages in the foregut and proboscis. Parasitology 1999, 118:469-478.
12. Oberle M., et al. Bottlenecks and the maintenance of minor genotypes during the life cycle of Trypanosoma brucei. PLoS Pathog. 2010, 6:e1001023.
13. Dyer N.A., et al. Flying tryps: survival and maturation of trypanosomes in tsetse flies. Trends Parasitol. 2013, 29:188-196.
14. Kounatidis I., Ligoxygakis P. Drosophila as a model system to unravel the layers of innate immunity to infection. Open Biol. 2012, 2:120075.
15. Genome sequence of the tsetse fly (Glossina morsitans): vector of African trypanosomiasis. Science 2014, 344:380-386. International Glossina Genome Initiative.
16. Weiss B.L., et al. Tsetse immune system maturation requires the presence of obligate symbionts in larvae. PLoS Biol. 2011, 9:e1000619.
17. Weiss B.L., et al. Obligate symbionts activate immune system development in the tsetse fly. J. Immunol. 2012, 188:3395-3403.
18. Weiss B.L., et al. Trypanosome infection establishment in the tsetse fly gut is influenced by microbiome-regulated host immune barriers. PLoS Pathog. 2013, 9:e1003318.
19. Akoda K., et al. Nutritional stress affects the tsetse fly's immune gene expression. Med. Vet. Entomol. 2009, 23:195-201.
20. Hao Z., et al. Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12648-12653.
21. Hu C., Aksoy S. Innate immune responses regulate trypanosome parasite infection of the tsetse fly Glossina morsitans morsitans. Mol. Microbiol. 2006, 60:1194-1204.
22. Wang J., et al. Interactions between mutualist Wigglesworthia and tsetse peptidoglycan recognition protein (PGRP-LB) influence trypanosome transmission. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12133-12138.
23. Wang J., Aksoy S. PGRP-LB is a maternally transmitted immune milk protein that influences symbiosis and parasitism in tsetse's offspring. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:10552-10557.
24. Ha E.M., et al. A direct role for dual oxidase in Drosophila gut immunity. Science 2005, 310:847-850.
25. Kumar S., et al. The role of reactive oxygen species on Plasmodium melanotic encapsulation in Anopheles gambiae. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14139-14144.
26. Hao Z., et al. Proventriculus (cardia) plays a crucial role in immunity in tsetse fly (Diptera: Glossinidiae). Insect Biochem. Mol. Biol. 2003, 33:1155-1164.
27. Lehane M.J., et al. Differential expression of fat body genes in Glossina morsitans morsitans following infection with Trypanosoma brucei brucei. Int. J. Parasitol. 2008, 38:93-101.
28. MacLeod E.T., et al. Antioxidants promote establishment of trypanosome infections in tsetse. Parasitology 2007, 134:827-831.
29. Macleod E.T., et al. Factors affecting trypanosome maturation in tsetse flies. PLoS ONE 2007, 2:e239.
30. Haines L.R., et al. Tsetse EP protein protects the fly midgut from trypanosome establishment. PLoS Pathog. 2010, 6:e1000793.
31. Dempsey W.L., Mansfield J.M. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J. Immunol. 1983, 130:405-411.
32. Shi M., et al. Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Eur. J. Immunol. 2003, 33:108-118.
33. Bosschaerts T., et al. Understanding the role of monocytic cells in liver inflammation using parasite infection as a model. Immunobiology 2009, 214:737-747.
34. Stijlemans B., et al. Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis. Microbes Infect. 2010, 12:389-399.
35. Stijlemans B., et al. The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches. Endocr. Metab. Immune Disord. Drug Targets 2010, 10:71-82.
36. Guegan F., et al. Erythrophagocytosis of desialylated red blood cells is responsible for anaemia during Trypanosoma vivax infection. Cell. Microbiol. 2013, 15:1285-1303.
37. Habila N., et al. Pathogenic mechanisms of Trypanosoma evansi infections. Res. Vet. Sci. 2012, 93:13-17.
38. Nishimura K., et al. Effect of Trypanosoma brucei brucei on erythropoiesis in infected rats. J. Parasitol. 2011, 97:88-93.
39. Paulnock D.M., et al. Modulation of innate immunity by African trypanosomes. Parasitology 2010, 137:2051-2063.
40. Lu W., et al. Trypanosoma congolense infections: induced nitric oxide inhibits parasite growth in vivo. J. Parasitol. Res. 2011, 2011:316067.
41. Wei G., et al. Intradermal infections of mice by low numbers of African trypanosomes are controlled by innate resistance but enhance susceptibility to reinfection. J. Infect. Dis. 2011, 203:418-429.
42. Salmon D., et al. Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host. Science 2012, 337:463-466.
43. Singh R., et al. Molecular regulation of Trypanosoma congolense-induced nitric oxide production in macrophages. PLoS ONE 2013, 8:e59631.
44. Manna P.T., et al. Life and times: synthesis, trafficking, and evolution of VSG. Trends Parasitol. 2014, 30:251-258.
45. Bockstal V., et al. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis. PLoS Pathog. 2011, 7:e1002089.
46. Radwanska M., et al. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog. 2008, 4:e1000078.
47. Obishakin E., et al. Chronic Trypanosoma congolense infections in mice cause a sustained disruption of the B-cell homeostasis in the bone marrow and spleen. Parasite Immunol. 2014, 36:187-198.
48. Tabel H., et al. Immunosuppression: cause for failures of vaccines against African trypanosomiases. PLoS Negl. Trop. Dis. 2013, 7:e2090.
49. Hertz C.J., Mansfield J.M. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell. Immunol. 1999, 192:24-32.
50. Mabbott N.A., et al. Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunol. 1995, 17:143-150.
51. De Muylder G., et al. A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity. PLoS Pathog. 2013, 9:e1003731.
52. Lopez R., et al. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J. Immunol. 2008, 181:4908-4917.
53. Namangala B. How the African trypanosomes evade host immune killing. Parasite Immunol. 2011, 33:430-437.
54. Stijlemans B., et al. A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology. J. Immunol. 2007, 179:4003-4014.
55. Bosschaerts T., et al. IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice. Eur. J. Immunol. 2011, 41:3270-3280.
56. Okwor I., et al. Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice. J. Infect. Dis. 2009, 200:361-369.
57. Guilliams M., et al. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J. Immunol. 2007, 179:2748-2757.
58. Schopf L.R., et al. Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein. Infect. Immun. 1998, 66:451-461.
59. Guilliams M., et al. Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. J. Infect. Dis. 2008, 198:781-791.
60. Ghassabeh G.H., et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 2006, 108:575-583.
61. Gautier E.L., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
62. Sieweke M.H., Allen J.E. Beyond stem cells: self-renewal of differentiated macrophages. Science 2013, 342:1242974.
63. Wynn T.A., et al. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
64. Bosschaerts T., et al. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog. 2010, 6:e1001045.
65. Guilliams M., et al. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol. 2009, 182:1107-1118.
66. Van Den Abbeele J., et al. Trypanosoma brucei modifies the tsetse salivary composition, altering the fly feeding behavior that favors parasite transmission. PLoS Pathog. 2010, 6:e1000926.
67. Caljon G., et al. Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response. Infect. Immun. 2006, 74:6324-6330.
68. Caljon G., et al. Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment. Int. J. Parasitol. 2006, 36:1025-1035.
69. Isnard A., et al. Impact of Leishmania metalloprotease GP63 on macrophage signaling. Front. Cell. Infect. Microbiol. 2012, 2:72.
70. Rolin S., et al. Simultaneous but independent activation of adenylate cyclase and glycosylphosphatidylinositol-phospholipase C under stress conditions in Trypanosoma brucei. J. Biol. Chem. 1996, 271:10844-10852.
71. Vincent I.M., et al. Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei. PLoS Negl. Trop. Dis. 2012, 6:e1618.
72. Shoda L.K., et al. DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect. Immun. 2001, 69:2162-2171.
73. Shirota H., et al. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J. Immunol. 2002, 169:787-794.
74. Harris T.H., et al. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect. Immun. 2007, 75:2366-2373.
75. Magez S., et al. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections. J. Infect. Dis. 2006, 193:1575-1583.
76. Noyes H., et al. Genetic and expression analysis of cattle identifies candidate genes in pathways responding to Trypanosoma congolense infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9304-9309.
77. Sunter J., et al. Determinants of GPI-PLC localisation to the flagellum and access to GPI-anchored substrates in trypanosomes. PLoS Pathog. 2013, 9:e1003566.
78. Coller S.P., et al. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J. Immunol. 2003, 171:1466-1472.
79. Leppert B.J., et al. The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. J. Immunol. 2007, 179:548-556.
80. Gómez-Rodríguez J., et al. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis. J. Infect. Dis. 2009, 200:1849-1860.
81. Kagira J.M., et al. Prevalence and types of coinfections in sleeping sickness patients in Kenya (2000/2009). J. Trop. Med. 2011, 2011:248914.
82. Dagenais T.R., et al. Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. J. Immunol. 2009, 183:3344-3355.
83. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
84. Hill E.W., et al. Understanding bovine trypanosomiasis and trypanotolerance: the promise of functional genomics. Vet. Immunol. Immunopathol. 2005, 105:247-258.
85. O'Gorman G.M., et al. Transcriptional profiling of cattle infected with Trypanosoma congolense highlights gene expression signatures underlying trypanotolerance and trypanosusceptibility. BMC Genomics 2009, 10:207.
86. Onyilagha C., et al. Low-dose intradermal infection with Trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection. Infect. Immun. 2014, 82:1074-1083.
87. Malissen B., et al. The origins and functions of dendritic cells and macrophages in the skin. Nat. Rev. Immunol. 2014, 14:417-428.
88. Prates D.B., et al. Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils. J. Leukoc. Biol. 2011, 90:575-582.
89. Peters N.C., et al. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 2009, 5:e1000484.
90. Amin D.N., et al. Distinct Toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei-infected mice. J. Infect. Dis. 2012, 205:320-332.
91. Prinz M., et al. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 2011, 14:1227-1235.
92. Shechter R., Schwartz M. Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J. Pathol. 2013, 229:332-346.
93. Vanhollebeke B., et al. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 2008, 320:677-681.
94. Raper J., et al. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J. Exp. Med. 1996, 183:1023-1029.
95. Vanhamme L., et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003, 422:83-87.
96. Shiflett A.M., et al. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J. Biol. Chem. 2005, 280:32578-32585.
97. Vanhollebeke B., et al. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4118-4123.
98. Molina-Portela M.P., et al. Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J. Exp. Med. 2008, 205:1721-1728.
99. Pays E., et al. The trypanolytic factor of human serum. Nat. Rev. Microbiol. 2006, 4:477-486.
100. Pérez-Morga D., et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 2005, 309:469-472.
101. Xong H.V., et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 1998, 95:839-846.
102. Uzureau P., et al. Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature 2013, 501:430-434.
103. Kieft R., et al. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:16137-16141.
104. Guilliams M. IL-10 and regulatory T cells limit the pathogenicity of African trypanosome infection. Faculty of Sciences, Cellular and Molecular Immunology 2008, 117. Vrije Universiteit Brussel.
105. Naessens J. Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome?. Int. J. Parasitol. 2006, 36:521-528.
106. Geerts S., et al. Trypanotolerance in small ruminants of sub-Saharan Africa. Trends Parasitol. 2009, 25:132-138.
107. Bucheton B., et al. Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol. 2011, 33:438-447.